Diabesity/Bibliography: Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>Charlie Player
mNo edit summary
imported>Gareth Leng
No edit summary
Line 2: Line 2:
==Review Articles==
==Review Articles==


#Magni P. ''et al.'' (2009) Feeding behavior in mammals including humans. ''Ann.N.Y.Acad.Sci.'' 1163:221-232. PMID 19456343
#Magni P ''et al.''(2009) Feeding behavior in mammals including humans ''Ann NY Acad Sci'' 1163:221-32. PMID 19456343


 
Speakman J ''et al.''(2008) Thrifty vs Drifty Gene Theory of Obesity Thrifty genes for obesity, an attractive but flawed idea, and an alternative perspective: the 'drifty gene' hypothesis ''Int J Obesity''  32:1611–7
JOHN PARK BIBLIOGRAPHY (WILL SORT THIS OUT SOON)
 
1) Speakman J. et al. (2008) Thrifty vs Drifty Gene Theory of Obesity Thrifty genes for obesity, an attractive but flawed idea, and an alternative perspective: the 'drifty gene' hypothesis. International Journal of Obesity (2008) 32, 1611–1617
The discussion of thrifty genes and drifty genes, on obesity and diabetes. Suggestion made that the case for Thrifty genes may not be correct, but rather a different hypothesis is proposed
The discussion of thrifty genes and drifty genes, on obesity and diabetes. Suggestion made that the case for Thrifty genes may not be correct, but rather a different hypothesis is proposed


2. Cameron, N et al. (2006) Childhood Obesity Contemporary Issues, p154, CRC press, Taylor and Francis Group.
Cameron N ''et al.'' (2006) ''Childhood Obesity Contemporary Issues'' p154, CRC press, Taylor and Francis Group. (Discusses how obesity relates very closely to Diabetes. Relates genetic and environmental factors and summarises the thrifty gene hypothesis.)
Discusses how obesity relates very closely to Diabetes.
Relates genetic and environmental factors and summarises the thrifty gene hypothesis .


3. Marchand L, (2002) The Pima Indians: Pathfinders for health, Obesity and Diabetes, Online resource: http://diabetes.niddk.nih.gov/DM/pubs/pima/obesity/obesity.htm
Marchand L (2002) The Pima Indians: Pathfinders for health, Obesity and Diabetes, Online resource: [http://diabetes.niddk.nih.gov/DM/pubs/pima/obesity/obesity.htm]
NIDDK research conducted on the Pima Indians for the past 30 years has helped scientists prove that obesity is a major risk factor in the development of diabetes. One-half of adult Pima Indians have diabetes and 95% of those with diabetes are overweight. Scientists use the "thrifty gene" theory proposed in 1962 by geneticist James Neel to help explain why many Pima Indians are overweight
NIDDK research conducted on the Pima Indians for the past 30 years has helped scientists prove that obesity is a major risk factor in the development of diabetes. One-half of adult Pima Indians have diabetes and 95% of those with diabetes are overweight. Scientists use the "thrifty gene" theory proposed in 1962 by geneticist James Neel to help explain why many Pima Indians are overweight


4. Neel JV (1962). "Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"?". Am. J. Hum. Genet. 14: 353–62. PMID 13937884.
Neel JV (1962) Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"? ''Am J Hum Genet'' 14:353–62. PMID 13937884. (The original paper that proposes the Thrifty genotype).
 
The original paper that proposes the Thrifty genotype.


Again evidence that suggests the Thrifty genotype in Type 2 diabetes. And obesity
Again evidence that suggests the Thrifty genotype in Type 2 diabetes. And obesity
Joffe, Barry; Paul Zimmet (1998-08-17). "The thrifty genotype in type 2 diabetes". Endocrine 9 (2): 139–141. doi:10.1385/ENDO:9:2:139.
Joffe, Barry; Paul Zimmet (1998-08-17). The thrifty genotype in type 2 diabetes ''Endocrine'' 9:139–41. doi:10.1385/ENDO:9:2:139.
 
Charlie Player. Visceral fat accumalation in obesity and type 2 diabetes references:
 
[1] Zimmet P, Alberti K, Shaw J (2001) Global and societal implications of the diabetes epidemic. Nature 414:782–787
 
[2] Langendonk JG, Kok P, Frölich M et al (2006) Decrease in visceral fat following diet-induced weight loss in upper body compared to lower body obese premenopausal women. Eur J Intern Med 17:465–469
 
[3] Palaniappan L, Camethon MR, Wang Y et al (2004) Predictors of the incident metabolic syndrome in adults. Diabetes Care 27:788–793
 
[4] Nieves DJ, Cnop M, Retzlaff B et al (2003) The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat. Diabetes 52:172–179.
 
[5] Turner NC, Clapham JC (1998) Insulin resistance, impaired glucose tolerance and non-insulin dependent diabetes, pathologic mechanism and treatment: current status and therapeutic possibility. Drug Res 51:36–94
 
[6] Gabriely I, Ma XH, Yang XM et al (2002) Removal of visceral fat prevents insulin resistance and glucose intolerance of aging. Diabetes 51:2951–2958
 
[7]  London E and Castonguay T. Diet and the role of 11β-hydroxysteroid dehydrogenase-1 on obesity. Nutritional Biochemistry Volume 20, Issue 7, July 2009, Pages 485-493.
 
[8]J. Solomon and J. Mayer, The effect of adrenalectomy on the development of the obese- hyperglycemic syndrome in ob-ob mice, Endocrinology 93 (2) (1973), pp. 510–512.


[9]Cnop, Landchild, Vidal et al. (2002) The concurrent accumalation of intra-adominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations. Diabetes 51:1005-1015.
Zimmet P ''et al.'' (2001) Global and societal implications of the diabetes epidemic. Nature 414:782–787


KATIE ROWLAND REFERENCES - will also sort out fully soon!
Langendonk JG ''et al.'' (2006) Decrease in visceral fat following diet-induced weight loss in upper body compared to lower body obese premenopausal women ''Eur J Intern Med'' 17:465–9
[[User:Katie Rowland|Katie Rowland]] 09:27, 20 October 2009 (UTC) My references - I have looked into treatment of diabetes/obesity - thought could maybe do how treating obesity will reduce diabetes? if its not along the right lines just let me know and i will change it!


1. Tamara S. Hannon, MD, Goutham Rao, MD and Silva A. Arslanian, MD. Childhood Obesity and Type 2 Diabetes Mellitus. Pediatrics. 2005;116: 473-480.
Palaniappan L ''et al.''(2004) Predictors of the incident metabolic syndrome in adults. ''Diabetes Care'' 27:788–93


2. J. Garber. Restaging insulin therapy for patients with type 2 diabetes. Diabetes Obes Metab. 2009;11: 1–5.
Nieves DJ ''et al.'' (2003) The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat. ''Diabetes'' 52:172–179.  


3. Monami M, Lamanna C, Marchionni N et al. Comparison of different drugs as add-on treatments to metformin in type 2 diabetes: a meta-analysis. Diabetes Res Clin Pr. 2008; 79: 196–203.
Turner NC, Clapham JC (1998) Insulin resistance, impaired glucose tolerance and non-insulin dependent diabetes, pathologic mechanism and treatment: current status and therapeutic possibility. ''Drug Res'' 51:36–94


4. Jermendy G. Can type 2 diabetes mellitus be considered preventable? Diabetess res clin pr. 2005; 68, S73-S81
Gabriely I ''et al.'' (2002) Removal of visceral fat prevents insulin resistance and glucose intolerance of aging. ''Diabetes'' 51:2951–8


5. Diabetes Prevention Program Research Group, Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin, N. Engl. J. Med. 346 (2002) 393–403.
London E, Castonguay T (2009) Diet and the role of 11β-hydroxysteroid dehydrogenase-1 on obesity. ''Nutritional Biochemistry'' 20:485-93


6. Bray G. Drug Treatment of Obesity. Reviews in Endocrine & Metabolic Disorders. 2001; 2.
Solomon J, Mayer J (1973) The effect of adrenalectomy on the development of the obese- hyperglycemic syndrome in ob-ob mice ''Endocrinology'' 93:510–2.


7. Chaputy JP and Tremblay A. Current and novel approaches to the drug therapy of obesity. Eur J Clin Pharmacol. 2006; 62
[9]Cnop, Landchild, Vidal ''et al.'' (2002) The concurrent accumalation of intra-adominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations. Diabetes 51:1005-15.


8. Lean MEJ, Powrie JK, Anderson AS, et al. Obesity, weight loss and prognosis in type 2 diabetes. Diabetic Med. 1990; 7:228-233.
Tamara S ''et al.'' (2005) Childhood obesity and type 2 diabetes mellitus. ''Pediatrics'' 116:473-80


9. Hartz AJ, Rupley DC Jr, Kalkhoff RD, et al : Relationship of obesity to diabetes: influences of obesity level and body fat distribution. Prev Med 1983; 12: 351-357
Garber J (2009). Restaging insulin therapy for patients with type 2 diabetes. ''Diabetes Obes Metab'' 11:1–5


==Primary Research Papers==
Monami M ''et al.'' (2008) Comparison of different drugs as add-on treatments to metformin in type 2 diabetes: a meta-analysis. ''Diabetes Res Clin Pr'' 79:196–203


'''Causes of type 2 diabetes in obese patients'''
Jermendy G (2005) Can type 2 diabetes mellitus be considered preventable? ''Diabetess res clin pr'' 68:S73-81
<br />


'''Endoplasmic reticulum stress causing hyper-activation of Jun kinases (JNKs), which leads to phosphorylation of insulin receptor substrates (IRSs), inhibiting insulin signalling:''' <br />
Diabetes Prevention Program Research Group, Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin, ''N Engl J. Med'' 346: (2002) 393–403


Umut Özcan, et al. (2004) Endoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes. ''Science'' '''306''', 457-461.<br />
Bray G. Drug Treatment of Obesity. Reviews in Endocrine & Metabolic Disorders. 2001; 2.


Giovanni Solinas, et al. (2007) JNK1 in Hematopoietically Derived Cells Contributes to Diet-Induced Inflammation and Insulin Resistance without Affecting Obesity. ''Cell Metabolism'' '''6''', 386–397.<br />
Chaputy JP, Tremblay A (2006) Current and novel approaches to the drug therapy of obesity ''Eur J Clin Pharmacol'' 62


'''Dysfunction of the pancreatic β-cells, which do not produce or secrete enough insulin to compensate for insulin resistance:'''<br />
Lean MEJ ''et al.'' (1990) Obesity, weight loss and prognosis in type 2 diabetes ''Diabetic Med'' 7:228-33


Hiroshi Karasawaa, Seiko Nagata-Gotoa, Kiyosumi Takaishia and Yoshihiro Kumagae. (2009) A novel model of type 2 diabetes mellitus based on obesity induced by high-fat diet in BDF1 mice. ''Metabolism Clinical and Experimental'' '''58''', 296–303.<br />
Hartz AJ ''et al.'' (1983) Relationship of obesity to diabetes: influences of obesity level and body fat distribution. ''Prev Med'' 12:351-57


Alexandra Butler et al. (2003) β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes. ''Diabetes'' '''52(1)''', 102-110.<br />
Umut Özcan ''et al.'' (2004) Endoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes. ''Science'' 306:457-61


Marc Donath et al. (2008) Islet Inflammation in Type 2 Diabetes: From metabolic stress to therapy. ''Diabetes Care'' '''31(2)''', 161-164.<br />
Solinas G ''et al.''(2007) JNK1 in Hematopoietically Derived Cells Contributes to Diet-Induced Inflammation and Insulin Resistance without Affecting Obesity. ''Cell Metabol'' 6:386–97


'''The hormone resistin, secreted by adipocytes, which causes resistance to insulin:'''<br />
Karasawaa H ''et al.'' (2009) A novel model of type 2 diabetes mellitus based on obesity induced by high-fat diet in BDF1 mice. ''Metabolism Clinical and Experimental'' 58:296–303


Claire M. Steppan, et al. (2001) The hormone resistin links obesity to diabetes. ''Nature'' '''409''', 307-312.<br />
Butler A ''et al.''(2003) β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes. ''Diabetes'' 52:102-10


Mohammed Qatanani et al. (2009) Macrophage-derived human resistin exacerbates adipose tissue inflammation and insulin resistance in mice. ''The Journal of Clinical Investigation'' '''119(3)''', 531-539.<br />
Donath M ''et al.''(2008) Islet inflammation in type 2 diabetes: from metabolic stress to therapy. ''Diabetes Care'' 31:161-4<br />
[[User:Nicholas Devlin|Nicholas Devlin]] 15:37, 26 October 2009 (UTC)


Claire M. Steppan, ''et al.''(2001) The hormone resistin links obesity to diabetes. ''Nature'' 409:307-312


Hannah Frost references - have been looking at implications of obesity in pregnancy i.e. increased risks to both mother and fetus of later onset of T2DM/NIDDM
Qatanani M ''et al.'' (2009) Macrophage-derived human resistin exacerbates adipose tissue inflammation and insulin resistance in mice. ''J Clin Invest'' 119:531-9<br />


Yogev, Y. and Visser, G. (2009) Obesity, gestational diabetes and pregnancy outcome. Seminars in Fetal and Neonatal Medicine, Volume 14, Issue 2, Pages 77-84
Yogev Y, Visser G (2009) Obesity, gestational diabetes and pregnancy outcome. ''Seminars in Fetal and Neonatal Medicine'' 14:77-84


Hattersley, A.T. and Tooke, J.E. (1999) The fetal insulin hypothesis: an alternative explanation of the association of low bir thweight with diabetes and vascular disease. Lancet. May 22;353(9166):1789-92.
Hattersley AT, Tooke JE (1999) The fetal insulin hypothesis: an alternative explanation of the association of low bir thweight with diabetes and vascular disease. ''Lancet''353:1789-92.


Chu, S.Y. et al. (2007) Maternal Obesity and Risk of Gestational Diabetes Mellitus. Diabetes Care. Vol. 30, No. 8,  Pages 2070-2076
Chu SY ''et al.''(2007) Maternal Obesity and Risk of Gestational Diabetes Mellitus. ''Diabetes Care'' 30:2070-6


Boney, C.M. et al. (2005) Metabolic Syndrome in Childhood: Association With Birth Weight, Maternal Obesity, and Gestational Diabetes Mellitus. PEDIATRICS. Vol. 115, No. 3
Boney CM ''et al.'' (2005) Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. ''Pediatrics'' 115  


http://www.webmd.com/baby/guide/pregnancy-gestational-diabetes
http://www.webmd.com/baby/guide/pregnancy-gestational-diabetes


Dunger, D. and Ong, K. (2009) Diabetes in pregnancy: a vicious circle? Research Horizons. Issue 8.
Dunger D, Ong K(2009) Diabetes in pregnancy: a vicious circle? ''Research Horizons'' Issue 8.

Revision as of 06:31, 11 October 2010

This article is developed but not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
A list of key readings about Diabesity.
Please sort and annotate in a user-friendly manner. For formatting, consider using automated reference wikification.

Review Articles

  1. Magni P et al.(2009) Feeding behavior in mammals including humans Ann NY Acad Sci 1163:221-32. PMID 19456343

Speakman J et al.(2008) Thrifty vs Drifty Gene Theory of Obesity Thrifty genes for obesity, an attractive but flawed idea, and an alternative perspective: the 'drifty gene' hypothesis Int J Obesity 32:1611–7 The discussion of thrifty genes and drifty genes, on obesity and diabetes. Suggestion made that the case for Thrifty genes may not be correct, but rather a different hypothesis is proposed

Cameron N et al. (2006) Childhood Obesity Contemporary Issues p154, CRC press, Taylor and Francis Group. (Discusses how obesity relates very closely to Diabetes. Relates genetic and environmental factors and summarises the thrifty gene hypothesis.)

Marchand L (2002) The Pima Indians: Pathfinders for health, Obesity and Diabetes, Online resource: [1] NIDDK research conducted on the Pima Indians for the past 30 years has helped scientists prove that obesity is a major risk factor in the development of diabetes. One-half of adult Pima Indians have diabetes and 95% of those with diabetes are overweight. Scientists use the "thrifty gene" theory proposed in 1962 by geneticist James Neel to help explain why many Pima Indians are overweight

Neel JV (1962) Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"? Am J Hum Genet 14:353–62. PMID 13937884. (The original paper that proposes the Thrifty genotype).

Again evidence that suggests the Thrifty genotype in Type 2 diabetes. And obesity Joffe, Barry; Paul Zimmet (1998-08-17). The thrifty genotype in type 2 diabetes Endocrine 9:139–41. doi:10.1385/ENDO:9:2:139.

Zimmet P et al. (2001) Global and societal implications of the diabetes epidemic. Nature 414:782–787

Langendonk JG et al. (2006) Decrease in visceral fat following diet-induced weight loss in upper body compared to lower body obese premenopausal women Eur J Intern Med 17:465–9

Palaniappan L et al.(2004) Predictors of the incident metabolic syndrome in adults. Diabetes Care 27:788–93

Nieves DJ et al. (2003) The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat. Diabetes 52:172–179.

Turner NC, Clapham JC (1998) Insulin resistance, impaired glucose tolerance and non-insulin dependent diabetes, pathologic mechanism and treatment: current status and therapeutic possibility. Drug Res 51:36–94

Gabriely I et al. (2002) Removal of visceral fat prevents insulin resistance and glucose intolerance of aging. Diabetes 51:2951–8

London E, Castonguay T (2009) Diet and the role of 11β-hydroxysteroid dehydrogenase-1 on obesity. Nutritional Biochemistry 20:485-93

Solomon J, Mayer J (1973) The effect of adrenalectomy on the development of the obese- hyperglycemic syndrome in ob-ob mice Endocrinology 93:510–2.

[9]Cnop, Landchild, Vidal et al. (2002) The concurrent accumalation of intra-adominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations. Diabetes 51:1005-15.

Tamara S et al. (2005) Childhood obesity and type 2 diabetes mellitus. Pediatrics 116:473-80

Garber J (2009). Restaging insulin therapy for patients with type 2 diabetes. Diabetes Obes Metab 11:1–5

Monami M et al. (2008) Comparison of different drugs as add-on treatments to metformin in type 2 diabetes: a meta-analysis. Diabetes Res Clin Pr 79:196–203

Jermendy G (2005) Can type 2 diabetes mellitus be considered preventable? Diabetess res clin pr 68:S73-81

Diabetes Prevention Program Research Group, Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin, N Engl J. Med 346: (2002) 393–403

Bray G. Drug Treatment of Obesity. Reviews in Endocrine & Metabolic Disorders. 2001; 2.

Chaputy JP, Tremblay A (2006) Current and novel approaches to the drug therapy of obesity Eur J Clin Pharmacol 62

Lean MEJ et al. (1990) Obesity, weight loss and prognosis in type 2 diabetes Diabetic Med 7:228-33

Hartz AJ et al. (1983) Relationship of obesity to diabetes: influences of obesity level and body fat distribution. Prev Med 12:351-57

Umut Özcan et al. (2004) Endoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes. Science 306:457-61

Solinas G et al.(2007) JNK1 in Hematopoietically Derived Cells Contributes to Diet-Induced Inflammation and Insulin Resistance without Affecting Obesity. Cell Metabol 6:386–97

Karasawaa H et al. (2009) A novel model of type 2 diabetes mellitus based on obesity induced by high-fat diet in BDF1 mice. Metabolism Clinical and Experimental 58:296–303

Butler A et al.(2003) β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes. Diabetes 52:102-10

Donath M et al.(2008) Islet inflammation in type 2 diabetes: from metabolic stress to therapy. Diabetes Care 31:161-4

Claire M. Steppan, et al.(2001) The hormone resistin links obesity to diabetes. Nature 409:307-312

Qatanani M et al. (2009) Macrophage-derived human resistin exacerbates adipose tissue inflammation and insulin resistance in mice. J Clin Invest 119:531-9

Yogev Y, Visser G (2009) Obesity, gestational diabetes and pregnancy outcome. Seminars in Fetal and Neonatal Medicine 14:77-84

Hattersley AT, Tooke JE (1999) The fetal insulin hypothesis: an alternative explanation of the association of low bir thweight with diabetes and vascular disease. Lancet353:1789-92.

Chu SY et al.(2007) Maternal Obesity and Risk of Gestational Diabetes Mellitus. Diabetes Care 30:2070-6

Boney CM et al. (2005) Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 115

http://www.webmd.com/baby/guide/pregnancy-gestational-diabetes

Dunger D, Ong K(2009) Diabetes in pregnancy: a vicious circle? Research Horizons Issue 8.